These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28557743)

  • 1. Understanding the Category B Recommendation for Serogroup B Meningococcal Vaccine.
    Marshall GS; Tan L
    Pediatrics; 2017 May; 139(5):. PubMed ID: 28557743
    [No Abstract]   [Full Text] [Related]  

  • 2. [Paediatric meningococcal meningitis in France: ACTIV/GPIP network results].
    Levy C; Taha MK; Bingen E; Cohen R;
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S49-54. PubMed ID: 22883366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New meningococcal vaccine recommendations under consideration.
    Turner JC
    J Am Coll Health; 2004; 53(2):89-91. PubMed ID: 15495886
    [No Abstract]   [Full Text] [Related]  

  • 4. Meningococcal serogroup B outbreaks and use of 4CMenB vaccine.
    Rose WE
    J Am Pharm Assoc (2003); 2014; 54(2):198-201. PubMed ID: 24632933
    [No Abstract]   [Full Text] [Related]  

  • 5. Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016.
    Soeters HM; Dinitz-Sklar J; Kulkarni PA; MacNeil JR; McNamara LA; Zaremski E; Chang HY; Lujan E; Granoff D; Lasky M; Montana B
    Emerg Infect Dis; 2017 May; 23(5):867-869. PubMed ID: 28418307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comments on the paper "the effectiveness of serogroup C meningococcal vaccine estimated from routine surveillance data" [P Rivest, R Allard, Vaccine 20 (2002) 2533-2536].
    De Wals P; De Serres G
    Vaccine; 2003 Jun; 21(19-20):2260-1; author reply 2262. PubMed ID: 12744854
    [No Abstract]   [Full Text] [Related]  

  • 7. The effectiveness of serogroup C meningococcal vaccine estimated from routine surveillance data.
    Rivest P; Allard R
    Vaccine; 2002 Jun; 20(19-20):2533-6. PubMed ID: 12057609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neisseria meningitidis B vaccines.
    Panatto D; Amicizia D; Lai PL; Gasparini R
    Expert Rev Vaccines; 2011 Sep; 10(9):1337-51. PubMed ID: 21919622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal education: more than just a vaccine.
    Kuenzi L
    J Am Coll Health; 2004; 53(2):93-4. PubMed ID: 15495887
    [No Abstract]   [Full Text] [Related]  

  • 10. Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement.
    Hogea C; Van Effelterre T; Vyse A
    Hum Vaccin Immunother; 2016; 12(2):451-66. PubMed ID: 26308796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal serogroup C serum and salivary antibody responses to meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with bivalent and quadrivalent meningococcal polysaccharide vaccine.
    Khalil M; Al-Mazrou Y; Findlow H; Chadha H; Bosch Castells V; Oster P; Borrow R
    Vaccine; 2014 Sep; 32(43):5715-21. PubMed ID: 25151042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction.
    Martinelli D; Fortunato F; Cappelli MG; Cozza V; Chironna M; Prato R
    J Immunol Res; 2015; 2015():710656. PubMed ID: 26351649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Which vaccination strategies for African meningococcal meningitis?].
    Saliou P; Debois H
    Bull Soc Pathol Exot; 2002 Dec; 95(5):326-30. PubMed ID: 12696369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serogroup B meningococcal vaccines.
    Zimmer SM; Stephens DS
    Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningitis B vaccine should not be given to all babies, committee says.
    Gulland A
    BMJ; 2016 Jul; 354():i3943. PubMed ID: 27417847
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil.
    Cardoso CW; Pinto LL; Reis MG; Flannery B; Reis JN
    Vaccine; 2012 Aug; 30(37):5541-6. PubMed ID: 22749604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines.
    Poland GA
    Clin Infect Dis; 2010 Mar; 50 Suppl 2():S45-53. PubMed ID: 20144016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningococcal serogroup B infections: a search for a broadly protective vaccine.
    Vermont CL; van den Dobbelsteen GP
    Expert Rev Vaccines; 2003 Oct; 2(5):673-81. PubMed ID: 14711328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal vaccine: New product, new recommendations.
    Campos-Outcalt D
    J Fam Pract; 2005 Apr; 54(4):324-6. PubMed ID: 15833222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quadrivalent meningococcal conjugate vaccines.
    Pace D; Pollard AJ; Messonier NE
    Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.